Related Experiment Video
Updated: Feb 23, 2026

Expression, Purification, Crystallization, and Enzyme Assays of Fumarylacetoacetate Hydrolase Domain-Containing Proteins
Published on: June 20, 2019
Substrate Recognition by a Dual-Function P450 Monooxygenase GfsF Involved in FD-891 Biosynthesis
Akimasa Miyanaga1, Ryuichi Takayanagi1, Takashi Furuya1
1Department of Chemistry, Tokyo Institute of Technology, 2-12-1 O-okayama, Meguro-ku, Tokyo, 152-8551, Japan.
GfsF, a P450 enzyme, performs dual epoxidation and hydroxylation reactions in macrolide biosynthesis. Structural and biochemical analyses reveal distinct substrate binding modes, explaining its reaction mechanism.
Area of Science:
- Biochemistry
- Structural Biology
- Enzymology
Background:
- GfsF is a P450 monooxygenase involved in macrolide polyketide FD-891 biosynthesis.
- It catalyzes sequential epoxidation and hydroxylation reactions, a complex enzymatic feat.
Purpose of the Study:
- To elucidate the structural and biochemical basis of GfsF's dual catalytic functions.
- To understand the mechanism regulating the order of epoxidation and hydroxylation.
Main Methods:
- Crystallography to determine the structure of ligand-free GfsF.
- Enzymatic assays using substrate analogues.
- Site-directed mutagenesis.
- Molecular docking models.
Main Results:
- The crystal structure revealed a predominantly hydrophobic substrate-binding pocket.
- Distinct substrate binding modes for epoxidation and hydroxylation were identified.
- These modes explain the enzyme's regulation of sequential oxidative reactions.
Conclusions:
- GfsF exhibits a sophisticated mechanism for performing sequential dual oxidations.
- The findings offer new insights into the reaction mechanisms of multifunctional P450 monooxygenases.
- This study provides a structural basis for understanding complex enzymatic catalysis.
More Related Videos
12:08Monitoring the Reductive and Oxidative Half-Reactions of a Flavin-Dependent Monooxygenase using Stopped-Flow Spectrophotometry
Published on: March 18, 2012
09:33Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
Related Concept Videos
Drug Metabolism: Phase I Reactions
Drug Metabolism: Phase II Reactions
Phase II Reactions: Glucuronidation
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids